Burcon Nutrascience Corporation (BU) Q1 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good afternoon, everyone, and thank you for participating in today's conference call to discuss Berken NutriScience Corporation's fiscal 2026 first quarter results and the June 30th, 2025. Joining us today are Kip Underwood, Berken's chief executive officer, and Alex Vardy, the company's interim chief financial officer. Following their presentation, we will open up the call for your questions. After the presentation, there will be an opportunity to ask questions. To join the question queue, you may press star 1 in your telephone keypad. Should you need assistance during the conference call, you may signal an operator by pressing star 0. Then, before we conclude today's call, I'll provide the company's safe harbor statement with important cautions regarding the forward-looking statements made during this call. Now, I would like to turn the call over to the CEO of Birkin, Mr. Kip Underwood. Sir, please go ahead. Thank you, operator. Good morning, good afternoon, and good evening to those on the call today, and thank you for attending our Q1 conference call. Before we get started, I would like to Preface this with we hope you all walk away with three fundamental takeaways. First, with our production facility in Galesburg, Illinois, working with our alliance partner, we have proven capability. We've proven we can produce our products at a cost and a quality that fully enable our business plan. Second, the customer response to our products and the market growth for proteins, in particular plant proteins, has exceeded our expectations. Put those two together. And the third key takeaway is, fundamentally, we are on track, we are on track to execute our business plan. Our safe harbor statement, which Dr. Lee will read. So today, we'll go through recent milestones. We'll talk...